NAMS
NewAmsterdam Pharma Company N.V.
$38.07
+$1.02(+2.75%)
62
Overall
55
Value
100
Tech
31
Quality
Market Cap
$3.63B
Volume
2.25M
52W Range
$14.06 - $37.07
Target Price
$40.55
Key Metrics Overview
| Market Cap | $3.63B | P/E Ratio | N/A |
| 52W High | $37.07 | 52W Low | $14.06 |
| Div Yield | N/A | Payout Ratio | N/A |
| EPS Growth 3Y | -63.3% | 52W Position | 104.3% |
| Overall Score | 62 | Value Score | 55 |
| Quality Score | 31 | Technical Score | 100 |
Growth Analysis
| EPS Current Est | $-1.47 | EPS Next Est | $-2.06 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NAMS | $38.07 | +2.8% | 2.25M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get NewAmsterdam Pharma Company N.V. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW